Sugarbud enters into Strategic Plant Genotyping and Tissue Culture Agreement with Segra

Published: December 6, 2019

Sugarbud enters into Strategic Plant Genotyping and Tissue Culture Agreement with Segra

Sugarbud Craft Growers Corp. has entered into a strategic plant genotyping and tissue culture agreement with Segra Biogenesis Corp., a wholly owned subsidiary of Segra International Corp.

Under the terms of the agreement, which include royalties tied to production success, Segra will provide Sugarbud with exclusive and proprietary cannabis cultivars as well as tissue culture technology and services for the preservation, regeneration, and production of key cultivars already held by Sugarbud.  Plant tissue culture, also known as plant micropropagation, is an advanced scientific technique utilized in many commercial agricultural applications to mass-produce plants with desirable traits. Using micropropagation, large volumes of sterile, healthy, disease-free, and genetically identical plantlets can be rapidly produced. Plant tissue culture eliminates systemic diseases in starting materials that can negatively impact yields and chemotype expression, while at the same time dramatically reducing the space required to maintain viable stock plants and produce healthy and uniform plants year-round.

“The genetic diversity, reliability and integrity of our cultivars is one of the cornerstones of our high-quality premium cannabis value proposition and our product leadership strategy,” stated Sugarbud CEO, John Kondrosky. “We believe that a reliable customer experience from batch-to-batch is an essential part of maintaining consumer confidence and trust in our brand.”

“Sugarbud is committed to quality and we are very excited to be partnering with Segra to ensure the quality and integrity of our cultivars. The benefits of tissue culture for the cannabis industry and consumers alike are significant and we look forward to collaborating closely with Segra to ensure that our customers experience only high-quality premium cannabis,” continued Mr. Kondrosky.

“The words premium and quality are thrown around often in this industry, however Sugarbud’s early adoption of tissue culture proves they are taking the necessary steps to ensure quality at the highest level,” stated Segra CEO, Todd McMurray. “It is this level of dedication and commitment to quality that builds lasting brands.”

About Sugarbud

Sugarbud is a federally licensed Alberta-based publicly traded cannabis company focused on the cultivation and production of high-quality premium cannabis, and product leadership through the development, production and distribution of value-added cannabis products in Canada.

Recent News

View All News Items

Latest Article

Legalization 2.0: IP and Regulatory Considerations for Edibles, Extracts and Topicals

Legalization 2.0: IP and Regulatory Considerations for Edibles, Extracts and Topicals

The legalization of cannabis edibles, extracts and topicals will expand the cannabis market and create new opportunities for producers, innovators and investors. According to a recent report from Deloitte, the Canadian market for these new cannabis products is expected to be worth $2.7 billion annually, with edibles accounting for more than half ($1.6 billion).

 

Read Article